REDUCE-IT: total ischemic events reduced across the full range of baseline LDL cholesterol and other key subgroups
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.3011
Abstract: REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial), a study of 8,179 randomized statin-treated patients with elevated triglycerides (TG) and increased cardiovascular (CV) risk followed for a median of 4.9 years, demonstrated robust results.… read more here.
Keywords: baseline ldl; endpoint; key secondary; baseline ... See more keywords